{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:38:07Z","timestamp":1788813487844,"version":"build-2803163510"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1208\/s12248-022-00730-0","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T02:02:50Z","timestamp":1657072970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Model-Informed Approach Supporting Approval of Adalimumab (HUMIRA) in Pediatric Patients with Ulcerative Colitis from a Regulatory Perspective"],"prefix":"10.1208","volume":"24","author":[{"given":"Ruo-Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Altepeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"730_CR1","doi-asserted-by":"crossref","unstructured":"Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Toruner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S, V.S. Group, Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis, N Engl J Med, 381 (2019) 1215-1226","DOI":"10.1056\/NEJMoa1905725"},{"key":"730_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1208\/s12248-019-0363-5","volume":"21","author":"Y Bi","year":"2019","unstructured":"Bi Y, Liu J, Wang J, Epps RE, Kettl D, Marcus K, Seo S, Zhu H, Wang Y. Model-informed drug development approach supporting approval of adalimumab (HUMIRA) in adolescent patients with hidradenitis suppurativa: a regulatory perspective. AAPS J. 2019;21:91.","journal-title":"AAPS J"},{"key":"730_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2217\/imt.15.114","volume":"8","author":"AS Patel","year":"2016","unstructured":"Patel AS, Suarez LD, Rosh JR. Adalimumab in pediatric Crohn\u2019s disease. Immunotherapy. 2016;8:127\u201333.","journal-title":"Immunotherapy"},{"key":"730_CR4","unstructured":"Drug label for adalimumab BLA 125057."},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/d41586-018-07276-2","volume":"563","author":"M Eisenstein","year":"2018","unstructured":"Eisenstein M. Ulcerative colitis: towards remission. Nature. 2018;563:S33.","journal-title":"Nature"},{"key":"730_CR6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/cpt.1363","volume":"105","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhu H, Madabushi R, Liu Q, Huang SM, Zineh I. Model-informed drug development: current US Regulatory Practice and Future Considerations. Clin Pharmacol Ther. 2019;105:899\u2013911.","journal-title":"Clin Pharmacol Ther"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-022-00730-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-022-00730-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-022-00730-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T14:07:09Z","timestamp":1658758029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-022-00730-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1208\/s12248-022-00730-0","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"18 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All listed authors are employees of the Food and Drug Administration of the USA. The authors report no financial interests or relationships with the commercial sponsors of any products discussed in this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The views expressed in this article are those of the authors and do not necessarily reflect the official views of the FDA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"79"}}